These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19944886)

  • 61. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders.
    Drake RE; McHugo GJ; Xie H; Fox M; Packard J; Helmstetter B
    Schizophr Bull; 2006 Jul; 32(3):464-73. PubMed ID: 16525088
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Comorbid addictive disorders and schizophrenia in the aspect of pathogenesis and treatment].
    Eryshev OF; Arkad'ev VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 2):67-73. PubMed ID: 21322149
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictors of smoking severity in patients with schizophrenia and alcohol use disorders.
    Meszaros ZS; Dimmock JA; Ploutz-Snyder RJ; Abdul-Malak Y; Leontieva L; Canfield K; Batki SL
    Am J Addict; 2011; 20(5):462-7. PubMed ID: 21838846
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Management of substance use disorder in schizophrenia patients: current guidelines.
    Drake RE
    CNS Spectr; 2007 Oct; 12(10 Suppl 17):27-32. PubMed ID: 17934387
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antipsychotic treatment discontinuation among individuals with schizophrenia and co-occurring substance use.
    Smelson DA; Tunis SL; Nyhuis AW; Faries DE; Kinon BJ; Ascher-Svanum H
    J Clin Psychopharmacol; 2006 Dec; 26(6):666-7. PubMed ID: 17110828
    [No Abstract]   [Full Text] [Related]  

  • 66. Course of substance abuse in patients with and without schizophrenia.
    Westermeyer JJ; Schneekloth TD
    Am J Addict; 1999; 8(1):55-64. PubMed ID: 10189515
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dual diagnosis treatment for patients with schizophrenia who are substance dependent.
    Tsuang JW; Ho AP; Eckman TA; Shaner A
    Psychiatr Serv; 1997 Jul; 48(7):887-9. PubMed ID: 9219296
    [No Abstract]   [Full Text] [Related]  

  • 68. The psychosocial treatment of schizophrenia -- Part II.
    Harv Ment Health Lett; 2001 Sep; 18(3):1-4. PubMed ID: 11572827
    [No Abstract]   [Full Text] [Related]  

  • 69. Shorter hospital stays and more rapid improvement among patients with schizophrenia and substance disorders.
    Ries RK; Russo J; Wingerson D; Snowden M; Comtois KA; Srebnik D; Roy-Byrne P
    Psychiatr Serv; 2000 Feb; 51(2):210-5. PubMed ID: 10655005
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A comparative study on schizophrenic patients with dual diagnosis.
    Modestin J; Gladen CJ; Christen S
    J Addict Dis; 2001; 20(4):41-51. PubMed ID: 11760925
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia.
    Krystal JH; D'Souza DC; Gallinat J; Driesen N; Abi-Dargham A; Petrakis I; Heinz A; Pearlson G
    Neurotox Res; 2006 Dec; 10(3-4):235-52. PubMed ID: 17197373
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mental health multimorbidity and poor quality of life in patients with schizophrenia.
    Bhalla IP; Stefanovics EA; Rosenheck RA
    Schizophr Res; 2018 Nov; 201():39-45. PubMed ID: 29709490
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of schizophrenia and comorbid substance use disorder.
    Green AI; Salomon MS; Brenner MJ; Rawlins K
    Curr Drug Targets CNS Neurol Disord; 2002 Apr; 1(2):129-39. PubMed ID: 12769622
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Negative symptoms in schizophrenia and substance-related disorders].
    Simon N; Belzeaux R; Adida M; Azorin JM
    Encephale; 2015 Dec; 41(6 Suppl 1):6S27-31. PubMed ID: 26776388
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treating comorbid substance use disorders in schizophrenia.
    Lubman DI; King JA; Castle DJ
    Int Rev Psychiatry; 2010; 22(2):191-201. PubMed ID: 20504059
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacotherapy of schizophrenia patients with comorbid substance abuse.
    Wilkins JN
    Schizophr Bull; 1997; 23(2):215-28. PubMed ID: 9165632
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [CO-OCCURRING SCHIZOPHRENIA AND SUBSTANCE USE DISORDER: ETIOLOGICAL THEORIES AND CHALLENGES IN ISRAEL].
    Florentin S; Raskin S
    Harefuah; 2017 Nov; 156(11):715-719. PubMed ID: 29198090
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Substance-abusing schizophrenics: do they self-medicate?
    Goswami S; Mattoo SK; Basu D; Singh G
    Am J Addict; 2004; 13(2):139-50. PubMed ID: 15204665
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An integrated treatment program for dually diagnosed patients.
    Bachmann KM; Moggi F; Hirsbrunner HP; Donati R; Brodbeck J
    Psychiatr Serv; 1997 Mar; 48(3):314-6. PubMed ID: 9057232
    [No Abstract]   [Full Text] [Related]  

  • 80. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia.
    Drake RE; Xie H; McHugo GJ; Green AI
    Schizophr Bull; 2000; 26(2):441-9. PubMed ID: 10885642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.